Assessing And Treating Clients With Anxiety Disorders Reflection

PLEASE PAY ATTENTION TO THE CASE STUDY and CHAPTERS ATTACHED

PLEASE FOLLOW THE PROMPTS OF THE WAY THE QUESTIONS WERE ASKED.

ZERO PLAGIARISM

FIVE REFERENCES

The Assignment

Examine Case Study: A Middle-Aged Caucasian Man With Anxiety. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

At each decision point stop to complete the following:

Decision #1
- Which decision did you select?
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?
Decision #2
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?
Decision #3
- Why did you select this decision? Support your response with evidence and references to the Learning Resources.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
- Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?

Also include how ethical considerations might impact your treatment plan and communication with clients.

chapter9_introduction.pdf
chapter5_introduction.pdf
GeneralizedAnxietyDisorder.docx
GeneralizedAnxietyDisordercase.docx

Generalized Anxiety Disorder Middle-Aged White Male With Anxiety

Asian girl

Decision Point One

Begin Zoloft 50 mg orally daily

RESULTS OF DECISION POINT ONE

· Client returns to clinic in four weeks

· Client informs you that he has no tightness in chest, or shortness of breath

· Client states that he noticed decreased worries about work over the past 4 or 5 days

· HAM-A score has decreased to 18 (partial response)

Select what the PMHNP should do next:

Increase dose to 75 mg orally daily

Increase dose to 100 mg orally daily

No change in drug/dose at this time

Generalized Anxiety Disorder Middle-Aged White Male With Anxiety

Middle age male

Decision Point One

Begin Tofranil (imipramine) 25 mg orally BID

RESULTS OF DECISION POINT ONE

· Client returns to clinic in four weeks

· Client reports a “slight” decrease in symptoms

· Client’s states that he no longer gets chest tightness, but still has occasional episodes of shortness of breath

· HAM-A score decreased from 26 to 22

Decision Point Two

Select what the PMHNP should do next:

Decision Point Two

Select what the PMHNP should do next:

Increase Tofranil to 50 mg orally BID

Continue current dose and reassess in 4 weeks

Add an augmentation agent such as BuSpar (buspirone) 5 mg orally TID

Generalized Anxiety Disorder Middle-Aged White Male With Anxiety

Middle age male

Decision Point One

Begin Buspirone 10 mg orally BID

RESULTS OF DECISION POINT ONE

· Client returns to clinic in four weeks

· Client reports slight decrease in symptoms

· Client states that he still feels very anxious

· HAM-A score decreased from 26 to 23

· Decision Point Two

· Select what the PMHNP should do next:

· Increase buspirone to 10 mg orally TID

· Increase buspirone to 20 mg orally TID

· Discontinue buspirone and begin Lexapro 10 mg orally daily